What is the purpose of a placebo control in clinical trials?

Study for the Clinical Research and Ethical Considerations Test. Enhance your understanding with multiple choice questions covering essential ethical guidelines and research methodologies. Prepare effectively for your test!

Multiple Choice

What is the purpose of a placebo control in clinical trials?

The main concept is establishing a baseline with a placebo to determine true efficacy of the active intervention. A placebo control provides a neutral comparison group that experiences similar expectations and study procedures as the treatment group but does not receive the active therapy. This setup helps isolate the drug’s real therapeutic effect from the placebo response—improvements that come from participants’ beliefs, the care they receive, or natural fluctuations in the condition. When outcomes are compared between the active-treatment group and the placebo group under blinded conditions, researchers can quantify how much of the observed benefit is due to the intervention itself rather than other factors. Using a placebo also helps reduce bias in outcome assessment, since participants and investigators are unaware of who receives the active treatment. It’s not about inducing treatment effects, replacing informed consent, or shortening study duration. Those are not the purposes of a placebo control. In current practice, placebo use is also weighed against ethical considerations and may be avoided when an effective standard therapy exists, with a different comparator used instead.

The main concept is establishing a baseline with a placebo to determine true efficacy of the active intervention. A placebo control provides a neutral comparison group that experiences similar expectations and study procedures as the treatment group but does not receive the active therapy. This setup helps isolate the drug’s real therapeutic effect from the placebo response—improvements that come from participants’ beliefs, the care they receive, or natural fluctuations in the condition. When outcomes are compared between the active-treatment group and the placebo group under blinded conditions, researchers can quantify how much of the observed benefit is due to the intervention itself rather than other factors. Using a placebo also helps reduce bias in outcome assessment, since participants and investigators are unaware of who receives the active treatment.

It’s not about inducing treatment effects, replacing informed consent, or shortening study duration. Those are not the purposes of a placebo control. In current practice, placebo use is also weighed against ethical considerations and may be avoided when an effective standard therapy exists, with a different comparator used instead.

More practice questions